Ventilator associated Pneumonia (VAP) The AMR Narrative Ventilator associated pneumonia: mechanisms, an appraisal of current therapies and the role for inhaled antibiotics in prevention and treatment ScienceDirect Evidence Based Practices to Prevent Ventilator Associated Pneumonia in an Intensive Care Unit in Bangladesh VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds Ventilator Associated Pneumonia (VAP) EMCrit Project